Camlin Fine Sciences News

The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Infinity Portfolio Holdings

Transcript of Earnings Call Q1FY25

Newspaper Advertisement - Un-audited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2024.

Earnings Call Audio Recording - Q1FY25

Investor Presentation Q1 FY25

Outcome of Board Meeting

UFR 30.06.2024

Intimation - Stop Transfer of Shares for issuance of duplicate share certificate

Intimation of Earnings call on Monday, August 12, 2024 with various investors and analysts to discuss the Un-audited financial results of the Company for the quarter ended June 30, 2024.

CAMLIN FINE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 ,inter alia, to consider and approve the standalone and consolidated un-audited financial results of the Company for the quarter ended June 30, 2024.

Scrutinizer''s Report and Voting Results of 31st Annual General Meeting held on July 31, 2024.

Summary of Proceedings and Voting Results of 31st Annual General Meeting held on July 31, 2024

Advertisement - Notice of 31st AGM published in Newspapers

Annual Report 2023 - 2024

Business Responsibility and Sustainability Report

AGM Notice

Certificate under Regulation 74 (5) of SEBI (DP) Regulations

Newspaper publication relating to 31st Annual General Meeting to be held on Wednesday, July 31, 2024 at 11.00 a.m. (IST) via VC/OAVM.

Intimation - Loss of share certificate

ESOP - Allotment

Intimation for Closure of Trading Window.

Intimation - Loss of Share Certificate

Shares of Camlin Fine Sciences witnessed a notable surge of 9% on the BSE on Wednesday, reaching the day's peak at Rs 113. This upswing followed the company's announcement regarding the complete acquisition of Vitafor Invest NV by its wholly owned subsidiary, Dresen Quimica SAPI De CV.

Our wholly owned subsidiary viz. Dresen Quimica SAPI De CV, Mexico, has entered into an Share Purchase Agreement (SPA) to acquire 100% stake in Vitafor Invest NV, Belgium and its underlying subsidiaries/associates.

Nifty opened higher but spent the session trading in a sideways trajectory without any directional bias. It closed with a loss.

Annual Secretarial Compliance Report

Transcript of the Investor call

Audited Results Published in News Papers

Earnings Call recording

Revised - Investor Presentation

Investor Presentation

Book Closure for AGM from July 25, 2024 to July 31, 2024

31st Annual General Meeting is scheduled on July 31, 2024

Appointment of Secretarial Auditor and Cost Auditor for FY 2024 - 2025

Appointment of Global Head - IT

Re-appointment of Directors at the ensuing AGM

Outcome of Board Meeting

AFR 31st March, 2024

Intimation of Conference call on Tuesday, May 21, 2024 with various investors and analysts to discuss the Audited financial results of the Company for the quarter and year ended March 31, 2024

CAMLIN FINE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2024 ,inter alia, to consider and approve Intimation about the Board Meeting to be held on May 20, 2024 to consider and approve the standalone and consolidated audited financial results for the quarter / year ended March 31, 2024